Product Information
CLONIDINE HCL ER 0.1 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.2290 per EA under NDC 50742024760. Its NADAC has been published 361 times since Sep 4, 2019.
FDA first approved this application on Mar 5, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the clonidine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.1 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742024760
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
CLONIDINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209675FDA Approved
3/5/2019
TE Code
AB1
On Market Since
3/5/2019
Pharmacological Classes
Price Statistics
The NADAC for CLONIDINE HCL ER 0.1 MG TABLET has been published 361 times since Sep 4, 2019, and over the history we have for it it has declined 88.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2290 per EA |
|---|---|
| All-time high | $1.9561 (Oct 16, 2019) |
| All-time low | $0.2005 (Nov 20, 2024) |
| 52-week high | $0.3026 |
| 52-week low | $0.2290 |
| Median price | $0.3580 |
| Average price | $0.5523 |
| Largest weekly change | +40.5% (Oct 20, 2021) |
| Weeks tracked | 361 |
| Tracking since | Sep 4, 2019 |
1W
N/A
1M
0.0%
3M
-9.0%
6M
-5.1%
1Y
-24.3%
3Y
-27.1%
5Y
-64.8%
All
-88.0%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clonidine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONIDINE HCL ER 0.1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONIDINE HCL ER 0.1 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.2290 per EA (NDC 50742024760), effective Jul 29, 2026.
How has the price of CLONIDINE HCL ER 0.1 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONIDINE HCL ER 0.1 MG TABLET has declined 88.0%. It has been tracked across 361 weekly CMS publications since Sep 4, 2019.
What are the highest and lowest recorded NADAC prices for CLONIDINE HCL ER 0.1 MG TABLET?
Since Sep 4, 2019, the NADAC for CLONIDINE HCL ER 0.1 MG TABLET has ranged from a low of $0.2005 (Nov 20, 2024) to a high of $1.9561 (Oct 16, 2019), with a median of $0.3580 per EA.
Are there cheaper alternatives to CLONIDINE HCL ER 0.1 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CLONIDINE HCL ER 0.1 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLONIDINE HCL ER 0.1 MG TABLET?
CLONIDINE HCL ER 0.1 MG TABLET (NDC 50742024760) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.